跳蚤和蜱虫控制药物市场、机会、成长动力、产业趋势分析和预测，2024-2032 年

全球跳蚤和蜱虫控制药物市场估值为 67 亿美元，预计 2024 年至 2032 年复合年增长率为 7.1%。对预防性保健措施的认知。美国宠物产品协会 (APPA) 的一份报告强调，67% 的美国家庭（即 8,500 万个家庭）拥有宠物，这是全球观察到的趋势。宠物数量的不断增长和宠物医疗保健支出的增加推动了对跳蚤和蜱虫药物的需求。产品配方的创新，例如新的活性成分和组合产品，也提高了治疗功效和安全性，从而带动了市场成长。

整个跳蚤和蜱虫控制药物行业根据产品类型、药物类型、动物类型、购买管道和地区进行分类。

根据产品类型，跳蚤和蜱虫控制药物市场分为咀嚼片、喷雾剂和其他产品类型。咀嚼片细分市场在 2023 年以 32 亿美元的销售额占据主导地位。它们消除了与局部解决方案相关的混乱，并最大限度地减少了儿童和其他宠物的暴露风险。这些药物提供全身作用，确保对宠物体内的跳蚤和蜱虫提供强有力的保护。咀嚼片所占据的巨大市场份额凸显了其日益流行和用户友好的性质。

根据药物类型，跳蚤和蜱虫控制药物市场分为处方药和非处方药。 2023 年，OTC 细分市场占据最高市场份额，达到 62.6%。它们可以在宠物商店、药局和线上平台上购买，让宠物主人无需兽医处方即可应对感染。非处方药解决方案通常更实惠，并且有针对不同宠物和需求的各种选项。人们对宠物健康意识的不断增强和直接购买的便利性巩固了非处方药领域的领先地位。

2023 年，北美跳蚤和蜱虫控制药物市场价值为 24 亿美元。对研发的大量投资催生了各种创新且有效的产品。主要製药公司的存在和完善的分销网络进一步增强了该地区的市场地位。对宠物健康和保健的关注，以及对产品安全和功效的严格监管，巩固了北美的领先地位。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 宠物健康意识不断增强
    • 增加宠物拥有量
    • 预防保健的重要性日益增加
  • 产业陷阱与挑战
    • 用药费用高
    • 不良反应
• 成长潜力分析
• 监管环境
• 未来市场趋势
• 波特的分析
• PESTEL分析

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 主要市场参与者的竞争分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品类型，2021 - 2032 年

• 主要趋势
• 咀嚼片
• 喷雾剂
• 其他产品类型

第 6 章：市场估计与预测：按药物类型，2021 - 2032 年

• 主要趋势
• 处方
• 场外交易

第 7 章：市场估计与预测：按动物类型，2021 - 2032

• 主要趋势
• 狗
• 猫
• 其他动物类型

第 8 章：市场估计与预测：按购买管道划分，2021 - 2032 年

• 主要趋势
• 兽医
• 药局和药房
• 宠物专卖店
• 超市/大卖场
• 在线的
• 其他购买管道

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 西班牙
  • 义大利
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 日本
  • 中国
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Bayer AG
• Boehringer Ingelheim International GmbH
• Central Garden and Pet Company
• Central Life Sciences
• Ceva Sante Animale
• Ecto Development LLC
• Elanco Animal Health Incorporated
• Hartz Mountain Corporation
• Merck and Co., Inc.
• Penn Veterinary Supply, Inc.
• Promika LLC
• PetIQ, LLC
• Virbac S.A.
• Zoetis Inc.

The Global Flea and Tick Control Medication Market was valued at USD 6.7 billion and is projected to witness a CAGR of 7.1% from 2024 to 2032. The market's expansion is propelled by the growing occurrence of flea and tick-borne diseases in pets, a rise in pet ownership, and greater awareness of preventive healthcare measures. A report from the American Pet Products Association (APPA) highlights that 67% of U.S. households, or 85 million families, own pets, a trend observed worldwide. This growing pet population and increased expenditure on pet healthcare propel the demand for flea and tick medications. Innovations in product formulations, such as new active ingredients and combination products, have also improved treatment efficacy and safety, leading to market growth.

The overall flea and tick control medication industry is classified based on the product type, medication type, animal type, purchase channel and region.

Based on product type, the flea and tick control medication market is categorized into chewables, sprays, and other product types. The chewables segment dominated the market with USD 3.2 billion in 2023. Chewable medications are favored for their convenience, palatability, and effectiveness. They eliminate the mess associated with topical solutions and minimize exposure risks to children and other pets. These medications provide systemic action, ensuring robust protection against fleas and ticks from within the pet's body. The substantial market share held by chewables underscores their rising popularity and user-friendly nature.

Based on medication type, the flea and tick control medication market is segmented into prescription and OTC. The OTC segment held the highest market share of 62.6% in 2023. OTC products dominate due to their accessibility and convenience. They are available at pet stores, pharmacies, and online platforms, allowing pet owners to tackle infestations without a veterinary prescription. OTC solutions are often more affordable and come in various options tailored to different pets and needs. Growing awareness of pet health and the ease of direct purchases solidify the OTC segment's leading position.

North America's flea and tick control medication market was valued at USD 2.4 billion in 2023. North America holds a dominant position due to high pet ownership rates, awareness of parasite-related health concerns, and a robust veterinary healthcare infrastructure. Significant investments in research and development have resulted in a diverse range of innovative and effective products. The presence of major pharmaceutical companies and a well-established distribution network further strengthens the region's market stance. Focus on pet health and wellness, alongside stringent regulations for product safety and efficacy, solidifies North America's leading position.

Table of Contents

Chapter 1 Methodology and Scope

• 1.1 Market scope and definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates and calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Rising awareness of pet health
    • 3.2.1.2 Increasing pet ownership
    • 3.2.1.3 Growing importance of preventive care
  • 3.2.2 Industry pitfalls and challenges
    • 3.2.2.1 High cost of medication
    • 3.2.2.2 Adverse effects
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Future market trends
• 3.6 Porter's analysis
• 3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Competitive analysis of major market players
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product Type, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Chewables
• 5.3 Sprays
• 5.4 Other product types

Chapter 6 Market Estimates and Forecast, By Medication Type, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Prescription
• 6.3 OTC

Chapter 7 Market Estimates and Forecast, By Animal Type, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Dogs
• 7.3 Cats
• 7.4 Other animal types

Chapter 8 Market Estimates and Forecast, By Purchase Channel, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Veterinarian
• 8.3 Drug and pharmacy stores
• 8.4 Pet specialty stores
• 8.5 Supermarket / hypermarket
• 8.6 Online
• 8.7 Other purchase channels

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Spain
  • 9.3.5 Italy
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 Japan
  • 9.4.2 China
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Bayer AG
• 10.2 Boehringer Ingelheim International GmbH
• 10.3 Central Garden and Pet Company
• 10.4 Central Life Sciences
• 10.5 Ceva Sante Animale
• 10.6 Ecto Development LLC
• 10.7 Elanco Animal Health Incorporated
• 10.8 Hartz Mountain Corporation
• 10.9 Merck and Co., Inc.
• 10.10 Penn Veterinary Supply, Inc.
• 10.11 Promika LLC
• 10.12 PetIQ, LLC
• 10.13 Virbac S.A.
• 10.14 Zoetis Inc.